FDA Approves Journavx Drug to Treat Pain Without Addiction RiskSuzetrigine is a new, non-addictive pain medication approved by the FDA, providing an alternative to opioids for pain management.
FDA approves drug from Boston-based company to treat pain without opioid effectsSuzetrigine, a non-addictive pain relief drug, is now approved by the FDA and promises a safer alternative to opioids.
FDA Approves Journavx Drug to Treat Pain Without Addiction RiskSuzetrigine is a new, non-addictive pain medication approved by the FDA, providing an alternative to opioids for pain management.
FDA approves drug from Boston-based company to treat pain without opioid effectsSuzetrigine, a non-addictive pain relief drug, is now approved by the FDA and promises a safer alternative to opioids.